Unilateral 6-hydroxydopamine lesion of dopamine neurons and subchronic l-DOPA administration in the adult rat alters the expression of the vesicular GABA transporter in different subsets of striatal neurons and in the substantia nigra, pars reticulata

Neuroscience

Volumn 145, Issue 2, 2007, Pages 727-737

  Wang, H ^a   Katz, J ^a   Dagostino, P ^a   Soghomonian, J J ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

6 hydroxydopamine; basal ganglia; dopamine; dyskinesia; GABA; levodopa

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; LEVODOPA; MESSENGER RNA; OXIDOPAMINE; PREPROENKEPHALIN; VESICULAR INHIBITORY AMINO ACID TRANSPORTER;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; CORPUS STRIATUM; CYTOSOL; DOPAMINERGIC NERVE CELL; GABAERGIC TRANSMISSION; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTRACELLULAR TRANSPORT; MALE; NERVE CELL LESION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA; SYNAPSE VESICLE;

ANIMALS; ANTIPARKINSON AGENTS; CORPUS STRIATUM; DOPAMINE; DOWN-REGULATION; DRUG ADMINISTRATION SCHEDULE; ENKEPHALINS; FUNCTIONAL LATERALITY; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION; LEVODOPA; MALE; NEURONS; OXIDOPAMINE; PARKINSONIAN DISORDERS; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION; UP-REGULATION; VESICULAR INHIBITORY AMINO ACID TRANSPORT PROTEINS;

EID: 33847361985     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.12.001     Document Type: Article

References (47)

1. Abercrombie E.D., Bonatz A.E., and Zigmond M.J. Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res 525 (1990) 36-44
2. Albin R.L., Young A.B., and Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci 12 (1989) 366-375
3. Bedet C., Isambert M.F., Henry J.P., and Gasnier B. Constitutive phosphorylation of the vesicular inhibitory amino acid transporter in rat central nervous system. J Neurochem 75 (2000) 1654-1663
4. Canales J.J., and Graybiel A.M. Patterns of gene expression and behavior induced by chronic dopamine treatments. Ann Neurol 47 (2000) S53-S59
5. Carta A., Fenu S., and Morelli M. Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of Parkinson's disease. Neurol Sci 22 (2001) 59-60
6. Carta A.R., Fenu S., Pala P., Tronci E., and Morelli M. Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats. Eur J Neurosci 18 (2003) 2563-2572
7. Cenci M.A., Lee C.S., and Bjorklund A. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur J Neurosci 10 (1998) 2694-2706
8. Cenci M.A. Transcription factors involved in the pathogenesis of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. Amino Acids 23 (2002) 105-109
9. Chadha A., Dawson L.G., Jenner P.G., and Duty S. Effect of unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway on GABA(A) receptor subunit gene expression in the rodent basal ganglia and thalamus. Neuroscience 95 (2000) 119-126
10. Chaudhry F.A., Reimer R.J., Bellocchio E.E., Danbolt N.C., Osen K.K., Edwards R.H., and Storm-Mathisen J. The vesicular GABA transporter, VGAT, localizes to synaptic vesicles in sets of glycinergic as well as GABAergic neurons. J Neurosci 18 (1998) 9733-9750
11. Colliver T.L., Pyott S.J., Achalabun M., and Ewing A.G. VMAT-mediated changes in quantal size and vesicular volume. J Neurosci 20 (2000) 5276-5282
12. De Gois S., Schafer M.K., Defamie N., Chen C., Ricci A., Weihe E., Varoqui H., and Erickson J.D. Homeostatic scaling of vesicular glutamate and GABA transporter expression in rat neocortical circuits. J Neurosci 25 (2005) 7121-7133
13. Dumoulin A., Rostaing P., Bedet C., Levi S., Isambert M.F., Henry J.P., Triller A., and Gasnier B. Presence of the vesicular inhibitory amino acid transporter in GABAergic and glycinergic synaptic terminal boutons. J Cell Sci 112 Pt 6 (1999) 811-823
14. Erickson J.D., De Gois S., Varoqui H., Schafer M.K., and Weihe E. Activity-dependent regulation of vesicular glutamate and GABA transporters: A means to scale quantal size. Neurochem Int 48 (2006) 643-649
15. Ferré S., O'Connor W.T., Svenningsson P., Bjorklund L., Lindberg J., Tinner B., Stromberg I., Goldstein M., Ogren S.O., Ungerstedt U., Fredholm B.B., and Fuxe K. Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms. Eur J Neurosci 8 (1996) 1545-1553
16. Gasnier B. The loading of neurotransmitters into synaptic vesicles. Biochimie 82 (2000) 327-337
17. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma Jr. F.J., and Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250 (1990) 1429-1432
18. Gerfen C.R., and Young III W.S. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res 460 (1988) 161-167
19. Gnanalingham K.K., and Robertson R.G. Chronic continuous and intermittent L-3,4-dihydroxyphenylalanine treatments differentially affect basal ganglia function in 6-hydroxydopamine lesioned rats: an autoradiographic study using [3H]flunitrazepam. Neuroscience 57 (1993) 673-681
20. Kang T.C., An S.J., Park S.K., Hwang I.K., Bae J.C., and Won M.H. Changed vesicular GABA transporter immunoreactivity in the gerbil hippocampus following spontaneous seizure and vigabatrin administration. Neurosci Lett 335 (2003) 207-211
21. Katz J., Nielsen K.M., and Soghomonian J.-J. Comparative effects of acute or chronic administration of levodopa to 6-hydroxydopamine-lesioned rats on the expression of glutamic acid decarboxylase in the neostriatum and GABAA receptors subunits in the substantia nigra, pars reticulata. Neuroscience 132 (2005) 833-842
22. Konradi C., Westin J.E., Carta M., Eaton M.E., Kuter K., Dekundy A., Lundblad M., and Cenci M.A. Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia. Neurobiol Dis 17 (2004) 219-236
23. Laprade N., and Soghomonian J.-J. Differential regulation of mRNA levels encoding for the two isoforms of glutamate decarboxylase (GAD65 and GAD67) by dopamine receptors in the rat striatum. Mol Brain Res 34 (1995) 65-74
24. Laprade N., and Soghomonian J.-J. Glutamate decarboxylase (GAD65) gene expression is increased by dopamine receptor agonists in a subpopulation of rat striatal neurons. Mol Brain Res 48 (1997) 333-345
25. Lindefors N., Brene S., Herrera-Marschitz M., and Persson H. Region specific regulation of glutamic acid decarboxylase mRNA expression by dopamine neurons in rat brain. Exp Brain Res 77 (1989) 611-620
26. McIntire S.L., Reimer R.J., Schuske K., Edwards R.H., and Jorgensen E.M. Identification and characterization of the vesicular GABA transporter. Nature 389 (1997) 870-876
27. Mercugliano M., Soghomonian J.J., Qin Y., Nguyen H.Q., Feldblum S., Erlander M.G., Tobin A.J., and Chesselet M.F. Comparative distribution of messenger RNAs encoding glutamic acid decarboxylases (Mr 65,000 and Mr 67,000) in the basal ganglia of the rat. J Comp Neurol 318 (1992) 245-254
28. Miller D.W., and Abercrombie E.D. Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats. J Neurochem 72 (1999) 1516-1522
29. Nielsen K.M., and Soghomonian J.J. Dual effects of intermittent or continuous L-DOPA administration on gene expression in the globus pallidus and subthalamic nucleus of adult rats with a unilateral 6-OHDA lesion. Synapse 49 (2003) 246-260
30. Nielsen K.M., and Soghomonian J.J. Normalization of glutamate decarboxylase gene expression in the entopeduncular nucleus of rats with a unilateral 6-hydroxydopamine lesion correlates with increased GABAergic input following intermittent but not continuous levodopa. Neuroscience 123 (2004) 31-42
31. Ochi M., Shiozaki S., and Kase H. L-DOPA-induced modulation of GABA and glutamate release in substantia nigra pars reticulata in a rodent model of Parkinson's disease. Synapse 52 (2004) 163-165
32. Pan H.S., Penney J.B., and Young A.B. Gamma-aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle. J Neurochem 45 (1985) 1396-1404
33. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press, San Diego
34. Pothos E.N., Larsen K.E., Krantz D.E., Liu Y., Haycock J.W., Setlik W., Gershon M.D., Edwards R.H., and Sulzer D. Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size. J Neurosci 20 (2000) 7297-7306
35. Sagné C., El Mestikawy S., Isambert M.F., Hamon M., Henry J.P., Giros B., and Gasnier B. Cloning of a functional vesicular GABA and glycine transporter by screening of genome databases. FEBS Lett 417 (1997) 177-183
36. Segovia J., Tillakaratne N.J., Whelan K., Tobin A.J., and Gale K. Parallel increases in striatal glutamic acid decarboxylase activity and mRNA levels in rats with lesions of the nigrostriatal pathway. Brain Res 529 (1990) 345-348
37. Smith Y., Bevan M.D., Shink E., and Bolam J.P. Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 86 (1998) 353-387
38. Soghomonian J.J., Gonzales C., and Chesselet M.F. Messenger RNAs encoding glutamate-decarboxylases are differentially affected by nigrostriatal lesions in subpopulations of striatal neurons. Brain Res 576 (1992) 68-79
39. Soghomonian J.J., and Chesselet M.F. Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat. Synapse 11 (1992) 124-133
40. Soghomonian J.J., and Laprade N. Glutamate decarboxylase (GAD67 and GAD65) gene expression is increased in a subpopulation of neurons in the putamen of Parkinsonian monkeys. Synapse 27 (1997) 122-132
41. Vemuganti R. Decreased expression of vesicular GABA transporter, but not vesicular glutamate, acetylcholine and monoamine transporters in rat brain following focal ischemia. Neurochem Int 47 (2005) 136-142
42. Yamamoto N, Pierce RC, Soghomonian JJ. Subchronic administration of l-DOPA to adult rats with a unilateral 6-hydroxydopamine lesion of dopamine neurons results in a sensitization of enhanced GABA release in the substantia nigra, pars reticulata. Brain Res 1123:196-200.
43. Yoshikawa K., Williams C., and Sabol S.L. Rat brain preproenkephalin mRNA. cDNA cloning, primary structure, and distribution in the central nervous system. J Biol Chem 259 (1984) 14301-14308
44. You Z.B., Herrera-Marschitz M., Nylander I., Goiny M., O'Connor W.T., Ungerstedt U., and Terenius L. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis-II. Effects of dopamine D1 and D2 receptor agonists. Neuroscience 63 (1994) 427-434
45. Zeng B.Y., Jolkkonen J., Jenner P., and Marsden C.D. Chronic L-DOPA treatment differentially regulates gene expression of glutamate decarboxylase, preproenkephalin and preprotachykinin in the striatum of 6-hydroxydopamine-lesioned rat. Neuroscience 66 (1995) 19-28
46. Zink M., and Spanagel R. Ethanol induces GAD67 and VGAT in slice cultures of newborn rat cerebral cortex. Neuroreport 16 (2005) 377-380
47. Zink M., Schmitt A., May B., Muller B., Braus D.F., and Henn F.A. Differential effects of long-term treatment with clozapine or haloperidol on GABA transporter expression. Pharmacopsychiatry 37 (2004) 171-174